{"id":15488,"date":"2025-11-20T16:10:33","date_gmt":"2025-11-20T10:40:33","guid":{"rendered":"https:\/\/www.torusdigital.com\/toruscope\/?p=15488"},"modified":"2025-11-20T16:10:33","modified_gmt":"2025-11-20T10:40:33","slug":"sudeep-pharma-ipo-opens-key-details-investors-shouldnt-miss","status":"publish","type":"post","link":"https:\/\/www.torusdigital.com\/toruscope\/news\/sudeep-pharma-ipo-opens-key-details-investors-shouldnt-miss\/","title":{"rendered":"Sudeep Pharma IPO Opens: Key Details Investors Shouldn\u2019t Miss"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_section el_id=&#8221;blog-inner-layout&#8221;][vc_row overlay_dotted=&#8221;&#8221;][vc_column el_class=&#8221;blog_primary&#8221;][vc_row_inner][vc_column_inner][vc_column_text css=&#8221;&#8221;]<\/p>\n<p>India\u2019s primary markets remain active, with quality issuers from healthcare and specialty ingredients drawing strong investor attention. Within this backdrop, Sudeep Pharma Limited opens its IPO on November 21, 2025. Below is a structured look at the company, its IPO specifics, and the outlook.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"About_Sudeep_Pharma_Ltd\"><\/span><strong>About Sudeep Pharma Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Incorporated in 1989, Sudeep Pharma manufactures pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients supplied to 100+ countries. It operates six manufacturing facilities (aggregate capacity ~50,000 MT) and a broad portfolio spanning calcium, iron, magnesium, zinc, potassium, and sodium mineral salts.<\/p>\n<p><strong>Businesses \/ Product Lines<\/strong><\/p>\n<ul>\n<li><strong>Pharma, Food &amp; Nutrition<\/strong> (excipients and mineral salts)<\/li>\n<li><strong>Specialty Ingredients<\/strong><\/li>\n<li><strong>Triturates<\/strong><\/li>\n<\/ul>\n<p><strong>Strengths<\/strong><\/p>\n<ul>\n<li>Leadership in a high-barrier, regulated niche with diversified portfolio<\/li>\n<li>Long relationships with global marquee customers<\/li>\n<li>Compliant, well-equipped plants and strong R&amp;D (in-house labs, pilot facilities)<\/li>\n<li>Workforce: 704 permanent employees (as of Dec 31, 2024)<\/li>\n<\/ul>\n<p><strong>Promoters: <\/strong>Sujit Jaysukh Bhayani, Avani Sujit Bhayani, Shanil Sujit Bhayani, Sujeet Jaysukh Bhayani HUF, Riva Resources Pvt. Ltd., Bhayani Family Trust.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sudeep_Pharma_IPO_Details\"><\/span><strong>Sudeep Pharma IPO Details<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tbody>\n<tr>\n<td>IPO Date<\/td>\n<td>November 21, 2025, to November 25, 2025<\/td>\n<\/tr>\n<tr>\n<td>Face Value<\/td>\n<td>\u20b91\u00a0per share<\/td>\n<\/tr>\n<tr>\n<td>Issue Price Band<\/td>\n<td>\u20b9563 to \u20b9593 per share<\/td>\n<\/tr>\n<tr>\n<td>Lot Size<\/td>\n<td>25 Shares<\/td>\n<\/tr>\n<tr>\n<td>Sale Type<\/td>\n<td>Fresh Capital-cum-Offer for Sale<\/td>\n<\/tr>\n<tr>\n<td>Total Issue Size<\/td>\n<td>1,50,92,750\u00a0shares<br \/>\n(aggregating up to \u20b9895.00\u00a0Cr)<\/td>\n<\/tr>\n<tr>\n<td>Fresh Issue<\/td>\n<td>16,02,024\u00a0shares<br \/>\n(aggregating up to \u20b995.00\u00a0Cr)<\/td>\n<\/tr>\n<tr>\n<td>Offer for Sale<\/td>\n<td>1,34,90,726\u00a0shares of \u20b91<br \/>\n(aggregating up to \u20b9800.00\u00a0Cr)<\/td>\n<\/tr>\n<tr>\n<td>Issue Type<\/td>\n<td>Bookbuilding\u00a0IPO<\/td>\n<\/tr>\n<tr>\n<td>Listing At<\/td>\n<td>BSE, NSE<\/td>\n<\/tr>\n<tr>\n<td>Share Holding Pre Issue<\/td>\n<td>11,13,46,602\u00a0shares<\/td>\n<\/tr>\n<tr>\n<td>Share Holding Post Issue<\/td>\n<td>11,29,48,626\u00a0shares<\/td>\n<\/tr>\n<tr>\n<td>Lead Manager<\/td>\n<td>ICICI Securities Ltd.<\/td>\n<\/tr>\n<tr>\n<td>Registrar<\/td>\n<td>MUFG Intime India Pvt. Ltd.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"Important_IPO_Timeline\"><\/span><strong>Important IPO Timeline<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table>\n<thead>\n<tr>\n<td><strong>Event<\/strong><\/td>\n<td><strong>Date<\/strong><\/td>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>IPO Open Date<\/td>\n<td>Fri, Nov 21, 2025<\/td>\n<\/tr>\n<tr>\n<td>IPO Close Date<\/td>\n<td>Tue, Nov 25, 2025<\/td>\n<\/tr>\n<tr>\n<td>Tentative Allotment<\/td>\n<td>Wed, Nov 26, 2025<\/td>\n<\/tr>\n<tr>\n<td>Initiation of Refunds<\/td>\n<td>Thu, Nov 27, 2025<\/td>\n<\/tr>\n<tr>\n<td>Credit of Shares to Demat<\/td>\n<td>Thu, Nov 27, 2025<\/td>\n<\/tr>\n<tr>\n<td>Tentative Listing Date<\/td>\n<td>Fri, Nov 28, 2025<\/td>\n<\/tr>\n<tr>\n<td>Cut-off time for UPI mandate confirmation<\/td>\n<td>5 PM on Tue, Nov 25, 2025<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><a href=\"https:\/\/torusdigital.go.link\/hgQeE\" target=\"_blank\" rel=\"noopener\"><br \/>\n<img decoding=\"async\" class=\"responsive-img\" src=\"https:\/\/www.torusdigital.com\/toruscope\/wp-content\/uploads\/2025\/07\/Desktop-1.jpg\" alt=\"\" \/><br \/>\n<\/a><\/p>\n<style>\n  .responsive-img {<br \/>\n    display: block;<br \/>\n    margin-left: auto;<br \/>\n    margin-right: auto;<br \/>\n    width: 100%;<br \/>\n    max-width: 900px;<br \/>\n<\/style>\n<h3><span class=\"ez-toc-section\" id=\"IPO_Reservation\"><\/span><strong>IPO Reservation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table>\n<thead>\n<tr>\n<td><strong>Investor Category<\/strong><\/td>\n<td><strong>Shares Offered<\/strong><\/td>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>QIB<\/td>\n<td>Not more than 50% of the Net Offer<\/td>\n<\/tr>\n<tr>\n<td>Retail<\/td>\n<td>Not less than 35% of the Net Offer<\/td>\n<\/tr>\n<tr>\n<td>NII<\/td>\n<td>Not less than 15% of the Net Offer<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"Sudeep_Pharma_IPO_Lot_Size\"><\/span><strong>Sudeep Pharma IPO Lot Size<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table>\n<thead>\n<tr>\n<td><strong>Application<\/strong><\/td>\n<td><strong>Lots<\/strong><\/td>\n<td><strong>Shares<\/strong><\/td>\n<td><strong>Amount<\/strong><\/td>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Retail (Min)<\/td>\n<td>1<\/td>\n<td>25<\/td>\n<td>\u20b914,825<\/td>\n<\/tr>\n<tr>\n<td>Retail (Max)<\/td>\n<td>13<\/td>\n<td>325<\/td>\n<td>\u20b91,92,725<\/td>\n<\/tr>\n<tr>\n<td>S-HNI (Min)<\/td>\n<td>14<\/td>\n<td>350<\/td>\n<td>\u20b92,07,550<\/td>\n<\/tr>\n<tr>\n<td>S-HNI (Max)<\/td>\n<td>67<\/td>\n<td>1,675<\/td>\n<td>\u20b99,93,275<\/td>\n<\/tr>\n<tr>\n<td>B-HNI (Min)<\/td>\n<td>68<\/td>\n<td>1,700<\/td>\n<td>\u20b910,08,100<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Sudeep_Pharma_Ltd_Financials_Restated_Consolidated\"><\/span><strong>Sudeep Pharma Ltd. Financials (Restated Consolidated)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Market Capitalisation (at issue terms):<\/strong> <strong>\u20b96,697.85 Cr<\/strong><\/p>\n<h3><span class=\"ez-toc-section\" id=\"Key_Company_Financials_%E2%82%B9_Crore\"><\/span><strong>Key Company Financials (\u20b9 Crore)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table>\n<thead>\n<tr>\n<td><strong>Period Ended<\/strong><\/td>\n<td><strong>30 Jun 2025<\/strong><\/td>\n<td><strong>31 Mar 2025<\/strong><\/td>\n<td><strong>31 Mar 2024<\/strong><\/td>\n<td><strong>31 Mar 2023<\/strong><\/td>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Assets<\/td>\n<td>922.26<\/td>\n<td>717.17<\/td>\n<td>513.87<\/td>\n<td>420.11<\/td>\n<\/tr>\n<tr>\n<td>Total Income<\/td>\n<td>130.08<\/td>\n<td>511.33<\/td>\n<td>465.38<\/td>\n<td>438.26<\/td>\n<\/tr>\n<tr>\n<td>Profit After Tax<\/td>\n<td>31.27<\/td>\n<td>138.69<\/td>\n<td>133.15<\/td>\n<td>62.32<\/td>\n<\/tr>\n<tr>\n<td>EBITDA<\/td>\n<td>48.57<\/td>\n<td>199.28<\/td>\n<td>187.76<\/td>\n<td>98.64<\/td>\n<\/tr>\n<tr>\n<td>Net Worth<\/td>\n<td>688.32<\/td>\n<td>497.53<\/td>\n<td>359.07<\/td>\n<td>226.29<\/td>\n<\/tr>\n<tr>\n<td>Reserves &amp; Surplus<\/td>\n<td>668.52<\/td>\n<td>481.11<\/td>\n<td>354.59<\/td>\n<td>221.88<\/td>\n<\/tr>\n<tr>\n<td>Total Borrowing<\/td>\n<td>135.97<\/td>\n<td>135.25<\/td>\n<td>75.03<\/td>\n<td>82.26<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"Key_Performance_Indicators_FY25_unless_specified\"><\/span><strong>Key Performance Indicators (FY25 unless specified)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table>\n<thead>\n<tr>\n<td><strong>KPI<\/strong><\/td>\n<td><strong>Value<\/strong><\/td>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Debt\/Equity<\/td>\n<td>0.20<\/td>\n<\/tr>\n<tr>\n<td>RoNW<\/td>\n<td>27.88%<\/td>\n<\/tr>\n<tr>\n<td>PAT Margin<\/td>\n<td>27.63%<\/td>\n<\/tr>\n<tr>\n<td>EBITDA Margin<\/td>\n<td>39.70%<\/td>\n<\/tr>\n<tr>\n<td>Price to Book<\/td>\n<td>12.93<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"EPS_PE_Ratio\"><\/span><strong>EPS &amp; P\/E Ratio<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table>\n<tbody>\n<tr>\n<td>Metrics<\/td>\n<td>Pre-IPO<\/td>\n<td>Post-IPO<\/td>\n<\/tr>\n<tr>\n<td><strong>EPS (\u20b9)<\/strong><\/td>\n<td>12.46<\/td>\n<td>11.07<\/td>\n<\/tr>\n<tr>\n<td><strong>P\/E (x)<\/strong><\/td>\n<td>47.61<\/td>\n<td>53.55<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"Objects_of_the_Issue\"><\/span><strong>Objects of the Issue<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<table>\n<thead>\n<tr>\n<td><strong>S.No.<\/strong><\/td>\n<td><strong>Purpose<\/strong><\/td>\n<td><strong>Amount (\u20b9 Cr)<\/strong><\/td>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Capex: machinery procurement for Nandesari Facility I production line<\/td>\n<td>75.81<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>General corporate purposes<\/td>\n<td>Balance<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3><span class=\"ez-toc-section\" id=\"Industry_Outlook\"><\/span><strong>Industry Outlook<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<ul>\n<li>Solid demand for high-quality excipients &amp; mineral salts from global pharma, food, and nutrition players.<\/li>\n<li>High regulatory barriers and compliance need favour established, audited manufacturers.<\/li>\n<li>Rising focus on nutrition &amp; wellness supports specialty ingredients growth.<\/li>\n<li>Diversified end-markets and geography reduce single-market dependency.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Sudeep_Pharma_IPO_Peer_Comparison\"><\/span><strong>Sudeep Pharma IPO: Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><a href=\"https:\/\/www.torusdigital.com\/ipo\/sudeep-pharma-ltd-ipo\">Sudeep Pharma IPO<\/a> can be compared with peers like <strong>Calcium Sandoz Ltd<\/strong><strong>, Anmol Chemicals, Gujarat Microwax Ltd, Loba Chemie, <\/strong>and <strong><a href=\"https:\/\/www.torusdigital.com\/stocks\/fine-organic-industries-ltd-share-price\">Fine Organics Industries Ltd<\/a><\/strong><strong>.<\/strong> Reviewing these companies helps investors understand Sudeep Pharma\u2019s position in the pharmaceutical excipients and specialty ingredients segment, enabling a clearer assessment of competitiveness, scale, and growth potential within the broader chemicals and healthcare materials industry.<\/p>\n<p><em><strong>You May Also Like:<\/strong><\/em><\/p>\n<ul>\n<li class=\"post-title\"><em><a href=\"https:\/\/www.torusdigital.com\/toruscope\/news\/gallard-steel-ipo-opens-key-details-investors-shouldnt-miss\/\">Gallard Steel IPO Opens: Key Details Investors Shouldn\u2019t Miss<\/a><\/em><\/li>\n<li class=\"post-title\"><em><a href=\"https:\/\/www.torusdigital.com\/toruscope\/news\/excelsoft-technologies-ipo-opens-key-details-investors-shouldnt-miss\/\">Excelsoft Technologies IPO Opens: Key Details Investors Shouldn\u2019t Miss<\/a><\/em><\/li>\n<li class=\"post-title\"><em><a href=\"https:\/\/www.torusdigital.com\/toruscope\/news\/capillary-technologies-ipo-opens-key-details-investors-shouldnt-miss\/\">Capillary Technologies IPO Opens: Key Details Investors Shouldn\u2019t Miss<\/a><\/em><\/li>\n<li class=\"post-title\"><em><a href=\"https:\/\/www.torusdigital.com\/toruscope\/news\/fujiyama-power-systems-ipo-opens-key-details-investors-shouldnt-miss\/\">Fujiyama Power Systems IPO Opens: Key Details Investors Shouldn\u2019t Miss<\/a><\/em><\/li>\n<li class=\"post-title\"><em><a href=\"https:\/\/www.torusdigital.com\/toruscope\/news\/tenneco-clean-air-ipo-opens-key-details-investors-shouldnt-miss\/\">Tenneco Clean Air IPO Opens: Key Details Investors Shouldn\u2019t Miss<\/a><\/em><\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Sudeep Pharma brings a scaled, globally diversified excipients and specialty ingredients franchise with strong margins, R&amp;D depth, and compliant capacities. The OFS-heavy construct provides supply while the fresh issue targets targeted capex at Nandesari.<\/p>\n<p>Considerations: valuation (P\/E stepping up post-issue), raw-material and FX sensitivity, and execution of capacity upgrades. Investors with a medium-to-long horizon seeking exposure to a high-barrier healthcare inputs business may evaluate accordingly.<\/p>\n<p>If you are exploring more investment opportunities, check out our dedicated page on <a href=\"https:\/\/www.torusdigital.com\/ipo\/upcoming-ipo\">upcoming IPO listings<\/a> to stay updated on the latest market offerings.<\/p>\n<p>[\/vc_column_text][\/vc_column_inner][vc_column_inner width=&#8221;1\/2&#8243;][vc_column_text css=&#8221;&#8221;][\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_id=&#8221;share_rating&#8221;][vc_column_inner width=&#8221;1\/2&#8243;][vc_column_text css=&#8221;&#8221;]<\/p>\n<h6>Rate this article<\/h6>\n<!-- FeedbackWP Plugin --><div  class=\"rmp-widgets-container rmp-wp-plugin rmp-main-container js-rmp-widgets-container js-rmp-widgets-container--15488 \"  data-post-id=\"15488\">    <!-- Rating widget -->  <div class=\"rmp-rating-widget js-rmp-rating-widget\">            <div class=\"rmp-rating-widget__icons\">      <ul class=\"rmp-rating-widget__icons-list js-rmp-rating-icons-list\">                  <li class=\"rmp-rating-widget__icons-list__icon js-rmp-rating-item\" data-descriptive-rating=\"Terrible!\" data-value=\"1\">              <i class=\"js-rmp-rating-icon rmp-icon rmp-icon--ratings rmp-icon--star rmp-icon--full-highlight\"><\/i>          <\/li>                  <li class=\"rmp-rating-widget__icons-list__icon js-rmp-rating-item\" data-descriptive-rating=\"Bad!\" data-value=\"2\">              <i class=\"js-rmp-rating-icon rmp-icon rmp-icon--ratings rmp-icon--star rmp-icon--full-highlight\"><\/i>          <\/li>                  <li class=\"rmp-rating-widget__icons-list__icon js-rmp-rating-item\" data-descriptive-rating=\"Okay!\" data-value=\"3\">              <i class=\"js-rmp-rating-icon rmp-icon rmp-icon--ratings rmp-icon--star rmp-icon--full-highlight\"><\/i>          <\/li>                  <li class=\"rmp-rating-widget__icons-list__icon js-rmp-rating-item\" data-descriptive-rating=\"Good!\" data-value=\"4\">              <i class=\"js-rmp-rating-icon rmp-icon rmp-icon--ratings rmp-icon--star rmp-icon--half-highlight js-rmp-replace-half-star\"><\/i>          <\/li>                  <li class=\"rmp-rating-widget__icons-list__icon js-rmp-rating-item\" data-descriptive-rating=\"Great!\" data-value=\"5\">              <i class=\"js-rmp-rating-icon rmp-icon rmp-icon--ratings rmp-icon--star \"><\/i>          <\/li>              <\/ul>    <\/div>    <p class=\"rmp-rating-widget__hover-text js-rmp-hover-text\"><\/p>    <button class=\"rmp-rating-widget__submit-btn rmp-btn js-submit-rating-btn\">      Submit Rating    <\/button>    <p class=\"rmp-rating-widget__results js-rmp-results \">       <span class=\"rmp-rating-widget__results__rating js-rmp-avg-rating\">3.7<\/span> \/ 5.  <span class=\"rmp-rating-widget__results__votes js-rmp-vote-count\">6<\/span>    <\/p>    <p class=\"rmp-rating-widget__not-rated js-rmp-not-rated rmp-rating-widget__not-rated--hidden\">          <\/p>    <p class=\"rmp-rating-widget__msg js-rmp-msg\"><\/p>  <\/div>  <!--Structured data -->        <\/div>\n<div id=\"emoji-overlay\" style=\"display: none;\">\n<div id=\"overlay-emoji\"><\/div>\n<div id=\"overlay-description\" class=\"emoji-text\"><\/div>\n<\/div>\n<div id=\"rating-popup\">\n<p><span id=\"popup-close\">\u00d7<\/span><\/p>\n<div class=\"popup_message\">\n<div id=\"popup-emoji\"><\/div>\n<div class=\"popup_innermsg\">\n<h5>Thank You for Rating Our Article!<\/h5>\n<p>Your feedback is incredibly valuable to us, and we&#8217;re thrilled to hear your thoughts.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<p>[\/vc_column_text][\/vc_column_inner][vc_column_inner width=&#8221;1\/2&#8243;][vc_column_text css=&#8221;&#8221;]<\/p>\n<h6>Share this article<\/h6>\n<div class=\"cscra-social square cscra-socials-679c8a1122c00\">\n        <a href=\"\/\/www.facebook.com\/sharer\/sharer.php?u=https%3A%2F%2Fwww.torusdigital.com%2Ftoruscope%2Fnews%2Fsudeep-pharma-ipo-opens-key-details-investors-shouldnt-miss%2F&t=Sudeep+Pharma+IPO+Opens%3A+Key+Details+Investors+Shouldn%E2%80%99t+Miss\" class=\"facebook\" data-toggle=\"tooltip\" data-placement=\"top\" title=\"Share On Facebook\" target=\"_blank\"><i class=\"fa fa-facebook\"><\/i><\/a>\n        <a href=\"\/\/twitter.com\/intent\/tweet?text=Sudeep+Pharma+IPO+Opens%3A+Key+Details+Investors+Shouldn%E2%80%99t+Miss&url=https%3A%2F%2Fwww.torusdigital.com%2Ftoruscope%2Fnews%2Fsudeep-pharma-ipo-opens-key-details-investors-shouldnt-miss%2F\" class=\"twitter\" data-toggle=\"tooltip\" data-placement=\"top\" title=\"Share On Twitter\" target=\"_blank\"><i class=\"fa-brands fa-x-twitter\"><\/i><\/a>\n        <a href=\"https:\/\/api.whatsapp.com\/send?text=Sudeep+Pharma+IPO+Opens%3A+Key+Details+Investors+Shouldn%E2%80%99t+Miss - https%3A%2F%2Fwww.torusdigital.com%2Ftoruscope%2Fnews%2Fsudeep-pharma-ipo-opens-key-details-investors-shouldnt-miss%2F\" class=\"whatsapp\" data-toggle=\"tooltip\" data-placement=\"top\" title=\"Share On WhatsApp\" target=\"_blank\"><i class=\"fa fa-whatsapp\"><\/i><\/a>\n        <a href=\"\/\/www.linkedin.com\/shareArticle?mini=true&url=https%3A%2F%2Fwww.torusdigital.com%2Ftoruscope%2Fnews%2Fsudeep-pharma-ipo-opens-key-details-investors-shouldnt-miss%2F&title=Sudeep+Pharma+IPO+Opens%3A+Key+Details+Investors+Shouldn%E2%80%99t+Miss\" class=\"linkedin\" data-toggle=\"tooltip\" data-placement=\"top\" title=\"Share On Linkedin\" target=\"_blank\"><i class=\"fa fa-linkedin\"><\/i><\/a>\n    <\/div>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][\/vc_section]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"[vc_section el_id=&#8221;blog-inner-layout&#8221;][vc_row overlay_dotted=&#8221;&#8221;][vc_column el_class=&#8221;blog_primary&#8221;][vc_row_inner][vc_column_inner][vc_column_text css=&#8221;&#8221;] India\u2019s primary markets remain active, with quality issuers from healthcare and specialty ingredients drawing strong investor attention. Within this backdrop, Sudeep Pharma Limited opens its IPO on November 21, 2025. Below is a structured look at the company, its IPO specifics, and the outlook. About Sudeep Pharma Ltd. Incorporated in","protected":false},"author":1,"featured_media":14110,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_sitemap_exclude":false,"_sitemap_priority":"","_sitemap_frequency":"","footnotes":""},"categories":[5,169],"tags":[],"class_list":["post-15488","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ipo","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Sudeep Pharma IPO Opens: What Investors Need to Know?<\/title>\n<meta name=\"description\" content=\"Sudeep Pharma IPO offers exposure to a global manufacturer of pharma excipients and specialty nutrition ingredients. See price band, dates, lot size, reservation, financials, KPIs, and objects of the issue.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.torusdigital.com\/toruscope\/news\/sudeep-pharma-ipo-opens-key-details-investors-shouldnt-miss\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sudeep Pharma IPO Opens: What Investors Need to Know?\" \/>\n<meta property=\"og:description\" content=\"Sudeep Pharma IPO offers exposure to a global manufacturer of pharma excipients and specialty nutrition ingredients. See price band, dates, lot size, reservation, financials, KPIs, and objects of the issue.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.torusdigital.com\/toruscope\/news\/sudeep-pharma-ipo-opens-key-details-investors-shouldnt-miss\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-20T10:40:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.torusdigital.com\/toruscope\/wp-content\/uploads\/2025\/08\/Aditya-Infotech-Ltd-Mainboard-IPO.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1441\" \/>\n\t<meta property=\"og:image:height\" content=\"466\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"torus\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"torus\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sudeep Pharma IPO Opens: What Investors Need to Know?","description":"Sudeep Pharma IPO offers exposure to a global manufacturer of pharma excipients and specialty nutrition ingredients. See price band, dates, lot size, reservation, financials, KPIs, and objects of the issue.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.torusdigital.com\/toruscope\/news\/sudeep-pharma-ipo-opens-key-details-investors-shouldnt-miss\/","og_locale":"en_US","og_type":"article","og_title":"Sudeep Pharma IPO Opens: What Investors Need to Know?","og_description":"Sudeep Pharma IPO offers exposure to a global manufacturer of pharma excipients and specialty nutrition ingredients. See price band, dates, lot size, reservation, financials, KPIs, and objects of the issue.","og_url":"https:\/\/www.torusdigital.com\/toruscope\/news\/sudeep-pharma-ipo-opens-key-details-investors-shouldnt-miss\/","og_site_name":"Blog","article_published_time":"2025-11-20T10:40:33+00:00","og_image":[{"width":1441,"height":466,"url":"https:\/\/www.torusdigital.com\/toruscope\/wp-content\/uploads\/2025\/08\/Aditya-Infotech-Ltd-Mainboard-IPO.webp","type":"image\/webp"}],"author":"torus","twitter_card":"summary_large_image","twitter_misc":{"Written by":"torus","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.torusdigital.com\/toruscope\/news\/sudeep-pharma-ipo-opens-key-details-investors-shouldnt-miss\/","url":"https:\/\/www.torusdigital.com\/toruscope\/news\/sudeep-pharma-ipo-opens-key-details-investors-shouldnt-miss\/","name":"Sudeep Pharma IPO Opens: What Investors Need to Know?","isPartOf":{"@id":"https:\/\/www.torusdigital.com\/toruscope\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.torusdigital.com\/toruscope\/news\/sudeep-pharma-ipo-opens-key-details-investors-shouldnt-miss\/#primaryimage"},"image":{"@id":"https:\/\/www.torusdigital.com\/toruscope\/news\/sudeep-pharma-ipo-opens-key-details-investors-shouldnt-miss\/#primaryimage"},"thumbnailUrl":"https:\/\/www.torusdigital.com\/toruscope\/wp-content\/uploads\/2025\/08\/Aditya-Infotech-Ltd-Mainboard-IPO.webp","datePublished":"2025-11-20T10:40:33+00:00","author":{"@id":"https:\/\/www.torusdigital.com\/toruscope\/#\/schema\/person\/468d817c6d51cdd85d58071858a47ce5"},"description":"Sudeep Pharma IPO offers exposure to a global manufacturer of pharma excipients and specialty nutrition ingredients. See price band, dates, lot size, reservation, financials, KPIs, and objects of the issue.","breadcrumb":{"@id":"https:\/\/www.torusdigital.com\/toruscope\/news\/sudeep-pharma-ipo-opens-key-details-investors-shouldnt-miss\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.torusdigital.com\/toruscope\/news\/sudeep-pharma-ipo-opens-key-details-investors-shouldnt-miss\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.torusdigital.com\/toruscope\/news\/sudeep-pharma-ipo-opens-key-details-investors-shouldnt-miss\/#primaryimage","url":"https:\/\/www.torusdigital.com\/toruscope\/wp-content\/uploads\/2025\/08\/Aditya-Infotech-Ltd-Mainboard-IPO.webp","contentUrl":"https:\/\/www.torusdigital.com\/toruscope\/wp-content\/uploads\/2025\/08\/Aditya-Infotech-Ltd-Mainboard-IPO.webp","width":1441,"height":466},{"@type":"BreadcrumbList","@id":"https:\/\/www.torusdigital.com\/toruscope\/news\/sudeep-pharma-ipo-opens-key-details-investors-shouldnt-miss\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Toruscope","item":"https:\/\/www.torusdigital.com\/toruscope\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.torusdigital.com\/toruscope\/.\/news\/"},{"@type":"ListItem","position":3,"name":"Sudeep Pharma IPO Opens: Key Details Investors Shouldn\u2019t Miss"}]},{"@type":"WebSite","@id":"https:\/\/www.torusdigital.com\/toruscope\/#website","url":"https:\/\/www.torusdigital.com\/toruscope\/","name":"Blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.torusdigital.com\/toruscope\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.torusdigital.com\/toruscope\/#\/schema\/person\/468d817c6d51cdd85d58071858a47ce5","name":"torus","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.torusdigital.com\/toruscope\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/09645f2c6ef6bbb3a78db22600040d547bed4438a393e0671d168d69d193bc19?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/09645f2c6ef6bbb3a78db22600040d547bed4438a393e0671d168d69d193bc19?s=96&d=mm&r=g","caption":"torus"},"sameAs":["https:\/\/stage.torusdigital.com\/blogs"],"url":"https:\/\/www.torusdigital.com\/toruscope\/author\/torus\/"}]}},"_links":{"self":[{"href":"https:\/\/www.torusdigital.com\/toruscope\/wp-json\/wp\/v2\/posts\/15488","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.torusdigital.com\/toruscope\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.torusdigital.com\/toruscope\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.torusdigital.com\/toruscope\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.torusdigital.com\/toruscope\/wp-json\/wp\/v2\/comments?post=15488"}],"version-history":[{"count":1,"href":"https:\/\/www.torusdigital.com\/toruscope\/wp-json\/wp\/v2\/posts\/15488\/revisions"}],"predecessor-version":[{"id":15489,"href":"https:\/\/www.torusdigital.com\/toruscope\/wp-json\/wp\/v2\/posts\/15488\/revisions\/15489"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.torusdigital.com\/toruscope\/wp-json\/wp\/v2\/media\/14110"}],"wp:attachment":[{"href":"https:\/\/www.torusdigital.com\/toruscope\/wp-json\/wp\/v2\/media?parent=15488"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.torusdigital.com\/toruscope\/wp-json\/wp\/v2\/categories?post=15488"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.torusdigital.com\/toruscope\/wp-json\/wp\/v2\/tags?post=15488"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}